- Home
- BTAI vs IFBD Comparison
BTAI vs IFBD Comparison
Compare BTAI & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- IFBD
- Stock Information
- Founded
- BTAI 2017
- IFBD 2001
- Country
- BTAI United States
- IFBD China
- Employees
- BTAI N/A
- IFBD N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- IFBD Computer Software: Prepackaged Software
- Sector
- BTAI Health Care
- IFBD Technology
- Exchange
- BTAI Nasdaq
- IFBD Nasdaq
- Market Cap
- BTAI 8.3M
- IFBD 8.4M
- IPO Year
- BTAI 2018
- IFBD 2021
- Fundamental
- Price
- BTAI $1.86
- IFBD $1.09
- Analyst Decision
- BTAI Buy
- IFBD
- Analyst Count
- BTAI 5
- IFBD 0
- Target Price
- BTAI $34.60
- IFBD N/A
- AVG Volume (30 Days)
- BTAI 295.5K
- IFBD 24.0K
- Earning Date
- BTAI 08-05-2025
- IFBD 01-01-0001
- Dividend Yield
- BTAI N/A
- IFBD N/A
- EPS Growth
- BTAI N/A
- IFBD N/A
- EPS
- BTAI N/A
- IFBD N/A
- Revenue
- BTAI $1,852,000.00
- IFBD $1,437,848.00
- Revenue This Year
- BTAI $5.03
- IFBD N/A
- Revenue Next Year
- BTAI $291.01
- IFBD N/A
- P/E Ratio
- BTAI N/A
- IFBD N/A
- Revenue Growth
- BTAI 5.47
- IFBD 413.52
- 52 Week Low
- BTAI $1.17
- IFBD $0.89
- 52 Week High
- BTAI $21.92
- IFBD $3.54
- Technical
- Relative Strength Index (RSI)
- BTAI 56.60
- IFBD 52.48
- Support Level
- BTAI $1.69
- IFBD $1.02
- Resistance Level
- BTAI $2.08
- IFBD $1.21
- Average True Range (ATR)
- BTAI 0.21
- IFBD 0.06
- MACD
- BTAI 0.02
- IFBD 0.01
- Stochastic Oscillator
- BTAI 57.89
- IFBD 47.62
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.